BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16091196)

  • 1. Diffuse large B-cell lymphomas with plasmablastic differentiation.
    Teruya-Feldstein J
    Curr Oncol Rep; 2005 Sep; 7(5):357-63. PubMed ID: 16091196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities.
    Colomo L; Loong F; Rives S; Pittaluga S; Martínez A; López-Guillermo A; Ojanguren J; Romagosa V; Jaffe ES; Campo E
    Am J Surg Pathol; 2004 Jun; 28(6):736-47. PubMed ID: 15166665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival of patients with CD20-negative variants of large B-cell lymphoma: an analysis of the National Cancer Data Base.
    Qunaj L; Castillo JJ; Olszewski AJ
    Leuk Lymphoma; 2018 Jun; 59(6):1375-1383. PubMed ID: 29019447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge.
    Montes-Moreno S; Montalbán C; Piris MA
    Leuk Lymphoma; 2012 Feb; 53(2):185-94. PubMed ID: 21812534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmablastic lymphomas with light chain restriction - plasmablastic extramedullary plasmacytomas?
    Boy SC; van Heerden MB; Raubenheimer EJ; van Heerden WF
    J Oral Pathol Med; 2010 May; 39(5):435-9. PubMed ID: 20537055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
    Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
    Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features of B-Cell lineage neoplasms with aberrant expression of CD3: a study of 21 cases.
    Oliveira JL; Grogg KL; Macon WR; Dogan A; Feldman AL
    Am J Surg Pathol; 2012 Sep; 36(9):1364-70. PubMed ID: 22895269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diffuse large B-cell lymphoma with expression of anaplastic lymphoma kinase protein: clinicopathologic and immunohistochemical study of 5 cases].
    Wang WY; Ma ZG; Li GD; Liu WP; Zhong L; Wang Y; Li JM; Li L; Jiang W; Tang Y; Liao DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Sep; 35(9):529-34. PubMed ID: 17134546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.
    Castillo JJ; Chavez JC; Hernandez-Ilizaliturri FJ; Montes-Moreno S
    Expert Rev Hematol; 2015 Jun; 8(3):343-54. PubMed ID: 25641215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral and extraoral plasmablastic lymphoma: similarities and differences in clinicopathologic characteristics.
    Hansra D; Montague N; Stefanovic A; Akunyili I; Harzand A; Natkunam Y; de la Ossa M; Byrne GE; Lossos IS
    Am J Clin Pathol; 2010 Nov; 134(5):710-9. PubMed ID: 20959653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD31 expression in plasmacytic/plasmablastic lesions.
    Plocharczyk E; Wakely PE
    Ann Diagn Pathol; 2013 Dec; 17(6):498-501. PubMed ID: 24074836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Gastric EBV-positive Diffuse Large B Cell Lymphoma (DLBCL) of the Elderly with Plasmablastic Differentiation.
    Hu M; Trevino J; Yang L; Cao D; Liu X; Lai J
    In Vivo; 2018; 32(2):413-417. PubMed ID: 29475930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic/plasmablastic tumors.
    Guedez L; Martinez A; Zhao S; Vivero A; Pittaluga S; Stetler-Stevenson M; Raffeld M; Stetler-Stevenson WG
    Blood; 2005 Feb; 105(4):1660-8. PubMed ID: 15479729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD20-negative diffuse large B cell lymphoma: a comprehensive analysis of 695 cases.
    Li J; Zhao S; Wang J; Chen J; Wen W; Zhang Q
    Tumour Biol; 2016 Mar; 37(3):3619-37. PubMed ID: 26459310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial plasma cell differentiation as a mechanism of lost major histocompatibility complex class II expression in diffuse large B-cell lymphoma.
    Wilkinson ST; Vanpatten KA; Fernandez DR; Brunhoeber P; Garsha KE; Glinsmann-Gibson BJ; Grogan TM; Teruya-Feldstein J; Rimsza LM
    Blood; 2012 Feb; 119(6):1459-67. PubMed ID: 22167754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Potential Therapeutic Targets for Plasmablastic Lymphoma Through Gene Expression Analysis: Insights into RAS and Wnt Signaling Pathways.
    Mansoor A; Kamran H; Akhter A; Seno R; Torlakovic EE; Roshan TM; Shabani-Rad MT; Elyamany G; Minoo P; Stewart D
    Mod Pathol; 2023 Aug; 36(8):100198. PubMed ID: 37105495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype.
    Petitjean B; Jardin F; Joly B; Martin-Garcia N; Tilly H; Picquenot JM; Brière J; Danel C; Mehaut S; Abd-Al-Samad I; Copie-Bergman C; Delfau-Larue MH; Gaulard P
    Am J Surg Pathol; 2002 Jun; 26(6):724-32. PubMed ID: 12023576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.
    Beltran B; Castillo J; Salas R; Quiñones P; Morales D; Hurtado F; Riva L; Winer E
    J Hematol Oncol; 2009 Feb; 2():11. PubMed ID: 19250532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases.
    Pan ZG; Zhang QY; Lu ZB; Quinto T; Rozenvald IB; Liu LT; Wilson D; Reddy V; Huang Q; Wang HY; Ren YS
    Am J Surg Pathol; 2012 Aug; 36(8):1129-40. PubMed ID: 22790853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.